Hongo, H., Kosaka, T., Suzuki, Y., Mikami, S., Fukada, J., & Oya, M. (2021). Topoisomerase II alpha inhibition can overcome taxane-resistant prostate cancer through DNA repair pathways. Nature Portfolio.
Chicago Style (17th ed.) CitationHongo, Hiroshi, Takeo Kosaka, Yoko Suzuki, Shuji Mikami, Junichi Fukada, and Mototsugu Oya. Topoisomerase II Alpha Inhibition Can Overcome Taxane-resistant Prostate Cancer Through DNA Repair Pathways. Nature Portfolio, 2021.
MLA (8th ed.) CitationHongo, Hiroshi, et al. Topoisomerase II Alpha Inhibition Can Overcome Taxane-resistant Prostate Cancer Through DNA Repair Pathways. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.